Glucagon-like peptide-1 analogs
US5981488A · kind A · utility
87Cited by
5References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 25, 1998 |
| Grant date | Nov 9, 1999 |
| Priority date | — |
| Expiry date | Mar 25, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides extended-action GLP-1 based peptides and compositions that are useful for treating diabetes and minimize the risk of hypoglycemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.